Initiation, adherence to AIs low for older women with DCIS

(HealthDay)—For older women with estrogen receptor (ER)-positive ductal carcinoma in situ (DCIS), initiation of aromatase inhibitors (AIs) and adherence to treatment are low, according to a study published online Oct. 25 in Cancer.

PDF) Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: A systematic review

Factors associated with weight gain in pre- and post-menopausal women receiving adjuvant endocrine therapy for breast cancer

Breast Cancer Treatment (PDQ®) - NCI

Adjuvant Hormonal Therapy Adherence in Breast Cancer - BCTT

PDF) Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer

Adjuvant Hormonal Therapy Adherence in Breast Cancer - BCTT

Adjuvant Hormonal Therapy Adherence in Breast Cancer - BCTT

Arthralgia in Breast Cancer Survivors: An Integrative Review of Endocrine Therapy

Endocrine Treatment of Young Patients with EBC